| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Common Stock | 118K | $438K | $3.70 | Jul 17, 2024 | Direct |
| PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | Stock Option (Right to Buy) | 37.5K | Feb 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jul 17, 2024 | 1 | -$9.62K | 4 | Jul 18, 2024 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jul 2, 2024 | 1 | -$19.8K | 4 | Jul 2, 2024 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Feb 12, 2024 | 2 | $0 | 4 | Feb 14, 2024 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jan 3, 2024 | 1 | -$58.1K | 4 | Jan 5, 2024 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jul 3, 2023 | 1 | -$40.1K | 4 | Jul 6, 2023 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Feb 10, 2023 | 2 | $0 | 4 | Feb 14, 2023 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jan 3, 2023 | 1 | -$27.4K | 4 | Jan 5, 2023 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jul 5, 2022 | 1 | -$15.4K | 4 | Jul 7, 2022 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Mar 3, 2022 | 2 | $0 | 4 | Mar 15, 2022 | Chief Commercial Officer |
| PBYI | PUMA BIOTECHNOLOGY, INC. | Jan 3, 2022 | 1 | -$15.1K | 4 | Jan 5, 2022 | Chief Commercial Officer |